Table 3.
Age range (years) | Serum prostate specific antigen (ng / ml) | |||
---|---|---|---|---|
Japanese2 (n=286) | Western7 (n=471) | MPUH | MPUH | |
Osteling et al | Osterling et al | (n=1899) | Mean + SD | |
40-49 | 0.0-2.0 | 0-2.5 | 0.0-2.1 | 1.0 ± 0.6 |
50-59 | 0.0-3.0 | 0-3.5 | 0.0-3.4 | 1.2 ±1.0 |
60-69 | 0.0-4.0 | 0-4.5 | 0.0-4.2 | 1.5 ± 1.2 |
> 70 | 0.0-5.0 | 0-6.5 | 0.0-5.0 | 1.9 ± 1.5 |
Age range (years) | Prostate volume (ml) | |||
Japanese2 | Western7 (n=286) | MPUH | Mean | |
Osteling et al | (n = 471) Osterling et al | (n=273) | (MPUH) ± SD | |
40-49 | 9-33 | 13-51 | 8-21 | 14.5 ± 3.1 |
50-59 | 9-35 | 15-60 | 6-42 | 17.7 ± 5.7 |
60-69 | 10-37 | 17-70 | 7-45 | 19.8 ± 7.4 |
> 70 | 11-40 | 20-82 | 5-64 | 24.8 ± 12.7 |
Age range (years) | Prostate specific antigen density (ng/ml/ml) | |||
Japanese2 (n=286) | Western7 (n=471) | MPUH | Mean | |
Osteling et al | Osterling et al | (n=273) | (MPUH) ± SD | |
40-49 | 0.0-0.10 | 0.0-0.08 | 0.0-0.15 | 0.07 ± 0.05 |
50-59 | 0.0-0.12 | 0.0-0.10 | 0.0-0.19 | 0.07 ± 0.05 |
60-69 | 0.0-0.15 | 0.0-0.11 | 0.0-0.19 | 0.08 ± 0.05 |
>70 | 0.0-0.18 | 0.0-0.13 | 0.0-0.20 | 0.10 ± 0.07 |